Study: NCT01147744

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasone Propionate 100mcg via ACCUHALER/DISKUS
Description: Fluticasone propionate 100mcg twice daily via ACCUHALER/DISKUS

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 100mg
Description: GSK2190915 100mg (1 x 100mg) once daily in the morning

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 10mg
Description: GSK2190915 10mg (1 x 10mg) once daily in the morning

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 300mg
Description: GSK2190915 300mg (1 x 100mg, 1 x 200mg tablets) once daily in the morning

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2190915 30mg
Description: GSK2190915 30mg (1 x 30mg) once daily in the morning

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Montelukast 10mg
Description: Montelukast 10mg (1 x 10mg capsule) once daily in the evening

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo GSK2190915 one tablet
Description: Placebo tablet, one tablet once daily in the morning

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo GSK2190915 one tablet
Description: Placebo tablet, one tablet once daily in the morning

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo GSK2190915 one tablet
Description: Placebo tablet, one tablet once daily in the morning

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo montelukast
Description: Placebo capsule once daily in the evening

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo montelukast
Description: Placebo capsule once daily in the evening

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo montelukast
Description: Placebo capsule once daily in the evening

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo montelukast
Description: Placebo capsule once daily in the evening

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo montelukast
Description: Placebo capsule once daily in the evening

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo montelukast
Description: Placebo capsule once daily in the evening

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo fluticasone propionate via ACCUHALER/DISKUS
Description: Inhaled placebo twice daily via ACCUHALER/DISKUS

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo fluticasone propionate via ACCUHALER/DISKUS
Description: Inhaled placebo twice daily via ACCUHALER/DISKUS

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo fluticasone propionate via ACCUHALER/DISKUS
Description: Inhaled placebo twice daily via ACCUHALER/DISKUS

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo fluticasone propionate via ACCUHALER/DISKUS
Description: Inhaled placebo twice daily via ACCUHALER/DISKUS

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo fluticasone propionate via ACCUHALER/DISKUS
Description: Inhaled placebo twice daily via ACCUHALER/DISKUS

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo fluticasone propionate via ACCUHALER/DISKUS
Description: Inhaled placebo twice daily via ACCUHALER/DISKUS

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo GSK2190915 two tablets
Description: Placebo tablet, two tablets once daily in the morning

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo GSK2190915 two tablets
Description: Placebo tablet, two tablets once daily in the morning

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo GSK2190915 two tablets
Description: Placebo tablet, two tablets once daily in the morning